Laurus To Sell 25% Stake To Nearly Double Generics Capacity In India
This article was originally published in PharmAsia News
Executive Summary
Laurus Labs agreed to sell about a 25% stake to Warbug Pincus for as much as $150 million and use the funds to build two additional factories in India, according to sources.